GPT and hypertensive disorder: We found that combined therapy with sorafenib may elevate the AST level (5.541, 2.04–14.48) and ALT level (4.48, 1.66–12.11), and increase the occurrence of clinical symptoms, such as pain/abdominal distension, hand-foot-skin reaction, hypertension, and fatigue.